Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature

RATIONAL: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are emerging problems in several countries. These infections require long and expensive treatment regimens. Recently, 2 new drugs, bedaquiline and delamanid, have been approved in several countries for use in...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Susanna, Bosis, Samantha, Tadolini, Marina, Bianchini, Sonia, Migliori, Giovanni Battista, Principi, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120920/
https://www.ncbi.nlm.nih.gov/pubmed/27861363
http://dx.doi.org/10.1097/MD.0000000000005347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120920/
https://www.ncbi.nlm.nih.gov/pubmed/27861363
http://dx.doi.org/10.1097/MD.0000000000005347

Ejemplares similares